The GSK name and elements of the incumbent orange logo have been retained in the new identity. Stevens says that the decision to retain the orange was partly driven by the fact that “the world of ...

Image courtesy Johnson & Johnson The new Johnson & Johnson logo conforms to current pharma design trends, as can also be seen in the Kenvue identity and in GSK’s recent redesign (again by Wolff Olins) ...

GSK on Wednesday said its vaccine sales would fall this year, after a weaker-than-expected performance for its respiratory ...

Investors in GSK plc (Symbol: GSK) saw new options begin trading today, for the May 2025 expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is the time ...

Pharmaceutical and healthcare company GlaxoSmithKline (GSK) is deploying a new IT infrastructure across its global operations to improve the integration of its data. The software supplied by ...

In addition to established platform technologies, GSK is building new platforms such as the Multiple Antigen-Presenting System (MAPS) and mRNA, key to addressing the most complex diseases.

GSK Plc is a healthcare company, which engages in the research, development, and manufacture of pharmaceutical medicines, vaccines, and consumer healthcare products. It operates through the ...

GSK (GSK.L), opens new tab has agreed to pay up to $2.2 billion to settle most lawsuits in U.S. state courts claiming that a discontinued version of the heartburn drug Zantac caused cancer ...

GlaxoSmithKline’s new head of pharmaceuticals, Luke Miels, will start work in September, after the company settled a contract dispute with UK rivals AstraZeneca. GSK poached Miels from ...

Questions remain about GSK’s ability to come up with new drugs and litigation over the antacid Zantac, and the stock still ...